Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in Germany
出版年份 2016 全文链接
标题
Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in Germany
作者
关键词
Abacavir, Azathioprine, Carbamazepine, Cetuximab, Cost-effectiveness, Personalized medicine, Pharmacogenetic test, Targeted therapy
出版物
ADVANCES IN THERAPY
Volume 33, Issue 9, Pages 1461-1480
出版商
Springer Nature
发表日期
2016-07-12
DOI
10.1007/s12325-016-0376-8
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cost-effectiveness of screening forHLA-A*31:01prior to initiation of carbamazepine in epilepsy
- (2015) Catrin O. Plumpton et al. EPILEPSIA
- Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic review
- (2015) Thomas Ondra et al. Journal of Biopharmaceutical Statistics
- Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reducing hypersensitivity reactions with HLA-B*5701 genotyping before abacavir prescription
- (2015) Ritika Kapoor et al. Pharmacogenetics and Genomics
- Cost-effectiveness of one-time genetic testing to minimize lifetime adverse drug reactions
- (2015) O Alagoz et al. PHARMACOGENOMICS JOURNAL
- The Cost-Effectiveness of a Pharmacogenetic Test: A Trial-Based Evaluation of TPMT Genotyping for Azathioprine
- (2014) Alexander J. Thompson et al. VALUE IN HEALTH
- What is personalized medicine: sharpening a vague term based on a systematic literature review
- (2013) Sebastian Schleidgen et al. BMC Medical Ethics
- Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand
- (2013) Waranya Rattanavipapong et al. EPILEPSIA
- Pharmacogenetics in clinical practice: how far have we come and where are we going?
- (2013) Julie A Johnson PHARMACOGENOMICS
- Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy
- (2013) Liming Weng et al. PHARMACOGENOMICS
- Factors affecting the development of adverse drug reactions (Review article)
- (2013) Muaed Jamal Alomar SAUDI PHARMACEUTICAL JOURNAL
- The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers
- (2012) A J Atherly et al. BRITISH JOURNAL OF CANCER
- Pharmacogenomics of adverse drug reactions: implementing personalized medicine
- (2012) C.-Y. Wei et al. HUMAN MOLECULAR GENETICS
- Cost-Effectiveness Analysis of Screening for KRAS and BRAF Mutations in Metastatic Colorectal Cancer
- (2012) Ajay S. Behl et al. JNCI-Journal of the National Cancer Institute
- Cost-Effectiveness Analysis of KRAS Testing and Cetuximab as Last-Line Therapy for Colorectal Cancer
- (2012) Takeru Shiroiwa et al. Molecular Diagnosis & Therapy
- Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore
- (2012) D. Dong et al. NEUROLOGY
- General principles of investigating and managing drug allergy
- (2011) Anthony Frew BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung
- (2011) Gilberto de Lima Lopes et al. CANCER
- Pharmacogenomic testing: Relevance in medical practice: Why drugs work in some patients but not in others
- (2011) J. P. KITZMILLER et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- KRAS and BRAF Mutation Analysis in Metastatic Colorectal Cancer: A Cost-effectiveness Analysis from a Swiss Perspective
- (2011) P. R. Blank et al. CLINICAL CANCER RESEARCH
- Professional Perspectives About Pharmacogenetic Testing and Managing Ancillary Findings
- (2011) Susanne B. Haga et al. Genetic Testing and Molecular Biomarkers
- Personalizing medicine with clinical pharmacogenetics
- (2011) Stuart A. Scott GENETICS IN MEDICINE
- Cost-effectiveness of KRAS testing in metastatic colorectal cancer patients in the United States and Germany
- (2011) Arthi Vijayaraghavan et al. INTERNATIONAL JOURNAL OF CANCER
- Facilitating Clinical Implementation of Pharmacogenomics
- (2011) David A. Mrazek et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Secondary Somatic Mutations Restoring BRCA1/2 Predict Chemotherapy Resistance in Hereditary Ovarian Carcinomas
- (2011) Barbara Norquist et al. JOURNAL OF CLINICAL ONCOLOGY
- Economic Evaluation of Genomic Test–Directed Chemotherapy for Early-Stage Lymph Node–Positive Breast Cancer
- (2011) Peter S. Hall et al. JNCI-Journal of the National Cancer Institute
- Acute Mesenteric Infarction Associated with Atrial Fibrillation
- (2011) Jia-Ming Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- A cost effectiveness analysis of thiopurine methyltransferase testing for guiding 6-mercaptopurine dosing in children with acute lymphoblastic leukemia
- (2011) Jennifer R. Donnan et al. PEDIATRIC BLOOD & CANCER
- Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations
- (2011) Dominik Rottenkolber et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Pharmacogenetics, Pharmacogenomics, and Individualized Medicine
- (2011) Q. Ma et al. PHARMACOLOGICAL REVIEWS
- Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice Guidelines
- (2010) D. Bovelli et al. ANNALS OF ONCOLOGY
- Human epidermal growth factor receptor 2 expression in early breast cancer patients: a Swiss cost–effectiveness analysis of different predictive assay strategies
- (2010) Patricia R. Blank et al. BREAST CANCER RESEARCH AND TREATMENT
- Cost-effectiveness analysis of HLA-B*5701 typing in the prevention of hypersensitivity to abacavir in HIV+ patients in Spain
- (2010) Diana Nieves Calatrava et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Pharmacogenetic tests in cancer chemotherapy: what physicians should know for clinical application
- (2010) Soo-Youn Lee et al. JOURNAL OF PATHOLOGY
- Thiopurine S-Methyltranferase Testing in Idiopathic Pulmonary Fibrosis: A Pharmacogenetic Cost-Effectiveness Analysis
- (2010) Jared T. Hagaman et al. LUNG
- Economic Efficiency of Genetic Screening to Inform the Use of Abacavir Sulfate in the Treatment of HIV
- (2010) Teresa L. Kauf et al. PHARMACOECONOMICS
- Predictive and prognostic molecular markers for cancer medicine
- (2010) Sunali Mehta et al. Therapeutic Advances in Medical Oncology
- Pharmacogenetics and pharmacogenomics of anticancer agents
- (2009) R. S. Huang et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Role of pharmacogenomics in drug discovery and development
- (2009) C Adithan et al. INDIAN JOURNAL OF PHARMACOLOGY
- Pharmacogenomics, Evidence, and the Role of Payers
- (2009) P.A. Deverka Public Health Genomics
- The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV
- (2008) Bruce R Schackman et al. AIDS
- The Potential Clinical and Economic Outcomes of Pharmacogenomic Approaches to EGFR-Tyrosine Kinase Inhibitor Therapy in Non–Small-Cell Lung Cancer
- (2008) Josh J. Carlson et al. VALUE IN HEALTH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now